Genentech announced the layoff of 93 workers, following previous cuts, highlighting ongoing evaluations of workforce needs and the impact of unsuccessful research programs.
Nadine Pinell stated, 'we regularly evaluate our current needs and future-focused research, and periodically have to make adjustments... including decisions around the right make-up of our workforce.'
The layoffs will affect various roles including scientists, engineers, and managers, with employees receiving severance that includes benefits, pay, and career services.
Genentech's recent job cuts come amid a larger trend of layoffs in the Bay Area's biotech sector, following challenges in replicating the success of its previous cancer drugs.
Collection
[
|
...
]